Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition.

Lorgunpai SJ, Grammas M, Lee DS, McAvay G, Charpentier P, Tinetti ME.

PLoS One. 2014 Feb 25;9(2):e89447. doi: 10.1371/journal.pone.0089447. eCollection 2014.

PMID:
24586786
[PubMed - in process]
Free PMC Article
2.

Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents.

Onoda T, Li W, Higai K, Koike K.

BMC Complement Altern Med. 2014 Feb 20;14:64. doi: 10.1186/1472-6882-14-64.

PMID:
24555682
[PubMed - in process]
Free PMC Article
3.

Thiazolidinediones: a 2010 perspective.

Krishnaswami A, Ravi-Kumar S, Lewis JM.

Perm J. 2010 Fall;14(3):64-72.

PMID:
20844707
[PubMed]
Free PMC Article
4.

Therapeutic Implications of PPARgamma in Cardiovascular Diseases.

Hasegawa H, Takano H, Komuro I.

PPAR Res. 2010;2010. pii: 876049. doi: 10.1155/2010/876049. Epub 2010 Aug 12.

PMID:
20814542
[PubMed]
Free PMC Article
5.

Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model--the Zucker diabetic rat.

Forcheron F, Basset A, Abdallah P, Del Carmine P, Gadot N, Beylot M.

Cardiovasc Diabetol. 2009 Mar 24;8:16. doi: 10.1186/1475-2840-8-16.

PMID:
19317897
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment.

Node K, Inoue T, Boyko V, Goldberg I, Fisman EZ, Adler Y, Schwammenthal E, Matas Z, Behar S, Tenenbaum A.

Cardiovasc Diabetol. 2009 Jan 28;8:5. doi: 10.1186/1475-2840-8-5.

PMID:
19173749
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk